USPTO serial 88242157
PILLPACK
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUKER, RACHEL EVE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PILLPACK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica Sganga
Jessica Sganga Knobbe Martens Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Pedometers; altimeters; scales; calculating machines; data processing apparatus; computers | ACTIVE | — |
| 010 | Surgical instruments and apparatus; medical apparatus and instruments for diagnosing, examining, treating, and monitoring viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dental apparatus and instruments, namely, dental picks, dental caps, dental inlays, dental onlays, dental burrs, dental bridges, dental mirrors, dental drills, dental prostheses, dental gloves, dental syringes, dental bite trays, oral irrigators, teeth protectors for dental purposes, X-ray apparatus for dental imaging; medical apparatus and instruments, namely, medical imaging apparatus; medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for medical use; testing apparatus for medical purposes, namely, apparatus for diagnosing, examining, and monitoring viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | ACTIVE | — |
| 035 | Advertising services; business management; business administration services; Providing office functions | ACTIVE | — |
| 042 | Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A9.com, Inc.
- Other trademarks owned by A9.com, Inc.
- Other trademarks owned by AMAZON TECHNOLOGIES, INC.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named PILLPACK
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 22, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 27, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 22, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 15, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 15, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 14, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 12, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 12, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 7, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 7, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 24, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 20, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 20, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 20, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 13, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 13, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 13, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 10, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 10, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 19, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 19, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 19, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 15, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 8, 2021 | ALIE | ASSIGNED TO LIE | — |
| Feb 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Nov 24, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 16, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 2, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 2, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 31, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 24, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 12, 2020 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 12, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 20, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 20, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 20, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 20, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 20, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 11, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 11, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 11, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 20, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 20, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 20, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 31, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |